Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Taro Pharmaceutical Industries Ltd | 8 | 0 | 2 | 0 | €39.20 | - | - |
| Korian S.A. | 1 | 0 | 1 | 0 | €2.77 | - | - |
| Uniqure B.V. | 1 | 0 | 1 | 0 | €4.39 | - | - |
| Blueprint Medicines Corp | 2 | 0 | 2 | 0 | €101.00 | - | - |
| Novocure Ltd | 1 | 1 | 0 | 0 | €14.44 | - | - |
| Sartorius AG VZO | 4 | 0 | 0 | 0 | €282.80 | - | - |
| Cosmo Pharmaceuticals S.A. | 1 | 0 | 0 | 0 | €73.50 | - | - |
| Viatris Inc. | 1 | 0 | 0 | 0 | €10.89 | - | - |
| Horizon Pharma plc | 7 | 0 | 0 | 0 | €110.40 | - | - |
| Integer Hldg | 1 | 0 | 0 | 0 | €102.00 | - | - |
| Canopy Growth Corp | 4 | 0 | 0 | 0 | €0.47 | €1.75 | 273.134% |
| Nektar Therapeutics | 3 | 1 | 1 | 0 | €1.40 | €3.70 | 164.475% |
| Emergent Biosolutions Inc. | 2 | 3 | 1 | 0 | €4.11 | €4.62 | 12.473% |
| Myriad Genetics | 5 | 2 | 0 | 0 | €18.50 | €23.22 | 25.500% |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 0 | €13.01 | €25.20 | 93.793% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €20.35 | €26.01 | 27.796% |
| Xencor Inc. | 9 | 1 | 1 | 0 | €22.60 | €31.74 | 40.438% |
| Perrigo Co. plc | 3 | 0 | 1 | 0 | €28.04 | €35.99 | 28.336% |
| Select Medical Holdings | 6 | 0 | 4 | 0 | €30.40 | €36.41 | 19.758% |
| Agios Pharmaceuticals Inc. | 6 | 0 | 3 | 0 | €31.00 | €38.99 | 25.770% |
| PTC Therapeutics Inc. | 14 | 5 | 3 | 0 | €30.20 | €41.51 | 37.459% |
| Hutchison China MediTech Ltd ADR | 5 | 0 | 0 | 0 | €18.40 | €45.10 | 145.082% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Halozyme Therapeutics Inc. | 14 | 0 | 3 | 0 | €38.34 | €50.33 | 31.280% |
| Catalent Inc. | 2 | 0 | 0 | 0 | €52.56 | €55.00 | 4.642% |